Patents by Inventor Laura Gualandi

Laura Gualandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11992560
    Abstract: The present invention relates to electro spun fibers for a local release in the central nervous system of an anti-inflammatory and a promyelinating agent over a defined time-window, in order to limit secondary neurodegeneration triggered by the glutamate release and supported by on-going inflammation. The combined treatment aimed to reduce inflammation and improve remyelination in the very early stage of the pathology improving the chronic clinical outcome of the lesion. In particular the present invention relates to electrospun polymeric fibers, wherein said fibers are loaded with 3,3,5-Triiodo-L-thyronine (T3) and Ibuprofen.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: May 28, 2024
    Assignee: ALMA MATER STUDIORUM—UNIVERSITÀ DI BOLOGNA
    Inventors: Laura Calza, Luciana Giardino, Maria Letizia Focarete, Chiara Gualandi, Maria-Laura Bolognesi, Nadia Passerini, Giampiero Pagliuca, Teresa Gazzotti, Elisa Zironi
  • Patent number: 11629199
    Abstract: The present application relates to specific binding members that bind carbonic anhydrase IX (CAIX). In particular, the present application relates to the treatment, diagnosis and detection of tumours, e.g. solid tumours, using specific binding members that bind CAIX. The specific binding member may be conjugated to a biocidal or cytotoxic molecule, or to a detectable label.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: April 18, 2023
    Inventors: Laura Gualandi, Sarah Wulhfard, Francesca Pretto, Catherine Pemberton-Ross, Alessandra Villa, Roberto De Luca
  • Patent number: 10125190
    Abstract: The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind collagen.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: November 13, 2018
    Assignee: Philogen S.P.A.
    Inventors: Laura Gualandi, Rajesh Kamath, Annette Schwartz Sterman
  • Patent number: 10098976
    Abstract: The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind: i) the IIICS isoform of fibronectin, ii) matrix-metalloproteinase 3 (MMP3), iii) periostin, or iv) tenascin-W.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: October 16, 2018
    Assignee: Philogen S.P.A.
    Inventors: Laura Gualandi, Sarah Wulhfard, Catherine Hutchinson, Mattia Matasci
  • Publication number: 20180193496
    Abstract: The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind: i) the IIICS isoform of fibronectin, ii) matrix-metalloproteinase 3 (MMP3), iii) periostin, or iv) tenascin-W.
    Type: Application
    Filed: July 28, 2015
    Publication date: July 12, 2018
    Applicant: Philogen S.P.A.
    Inventors: Laura Gualandi, Sarah Wuhlfard, Catherine Hutchinson, Mattia Matasci
  • Publication number: 20170226196
    Abstract: The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind collagen.
    Type: Application
    Filed: July 28, 2015
    Publication date: August 10, 2017
    Applicant: Philogen S.P.A.
    Inventors: Laura Gualandi, Rajesh Kamath, Annette Schwartz Sterman